Skip to content
What We Do
For Providers
Model-Informed Precision Dosing
Clinical Decision Support
Real-Time Clinical Analytics
Infectious Disease
Bone Marrow Transplant
Other Therapeutic Areas
Customers
For Life Sciences
Precision Dosing in Clinical Trials
Real-time Pharmacology Analytics in Clinical Trials
Companion Applications
How We Do It
InsightRX Nova
InsightRX Apollo
Continuous Learning
Integrations
Drug Modules
Security
Company
Mission & Values
Leadership
Careers
Press Releases
Press Releases
Media
Resources
Product Innovation
Scientific Publications
Thought Leadership
White Papers
Contact Us
FEATURED
Beyond Vancomycin: Why Linezolid & Daptomycin Call for Precision Dosing
Press Releases
Press Releases
Dec 3, 2024
InsightRX to Present Latest Research and Platform Enhancements at ASHP 2024 Midyear Conference
Press Releases
Oct 29, 2024
InsightRX to Present Abstracts On Vancomycin Pharmacokinetic Model Performance, MIPD Protocols at ACoP15 Conference
Press Releases
Oct 8, 2024
InsightRX to Present Three Abstracts Demonstrating Advances in Bayesian Precision Dosing at IDWeek 2024
Press Releases
Aug 27, 2024
InsightRX Announces the Release of InsightRX GEMINI Model-selection Algorithm
Press Releases
Jun 13, 2024
Northern Arizona Healthcare (NAH) Partners with InsightRX on the First Commercial Precision Dosing Model For Heparin
Press Releases
May 14, 2024
InsightRX Continues Momentum in Precision Dosing with Client Growth, New Scientific Breakthroughs
Press Releases
Apr 30, 2024
InsightRX Unveils Apollo Gold, a Powerful New Tier of the Apollo Analytics Platform
Press Releases
Feb 27, 2024
How PKPD Modeling Improves Therapeutic Target Attainment with Individualized Dosing
Press Releases
Feb 24, 2024
CIBC Innovation Banking Provides Growth Capital to InsightRX
PREV
1
2
3
4
5
NEXT
